FDA Joins NIH and EPA in Tox21 Effort | GenomeWeb

This article has been updated with quotes and additional information from NCGC Director Christopher Austin.

By Matt Jones

NEW YORK (GenomeWeb News) – The Tox21 program that brings together the National Institutes of Health and the Environmental Protection Agency to develop new ways to predict the effects of chemicals on humans and the environment has gained a new partner in the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.